Showing posts with label Study. Show all posts
Showing posts with label Study. Show all posts

Saturday, August 21, 2010

Mesothelioma Study Evaluates Varied Impacts of the Cancer

Wednesday, August 11th, 2010

In a study published in the European Journal of Cancer Care, researchers from the United Kingdom reviewed the experiences patients face while living with mesothelioma cancer. The study was titled,

Thursday, August 19, 2010

Mesothelioma Study Investigates Role of Mesothelin Gene in Cancer Development

Friday, August 13th, 2010

Japanese researchers recently investigated the mechanism by which mesothelin is expressed in malignant mesothelioma. The study was published in the peer-reviewed medical journal Human Pathology.

Mesothelioma is a rare cancer almost exclusively caused by asbestos exposure. Because there is no cure for this disease, the mesothelioma life expectancy for most patients ranges between four and 18 months after diagnosis. Although no cure currently exists, some mesothelioma patients are diagnosed early enough to qualify for a combination of aggressive therapies, such as surgery, chemotherapy and radiation. The combination of therapies, known as multimodality therapy, currently has the best chance of extending a patient’s life expectancy.

Authors of the study explain,